Table 3 Survival, complications, and event-free days
Variable | RBC transfusion strategy | |
|---|---|---|
Restrictive (n = 216) | Liberal (n = 195) | |
28-day survival, n (%) | 199 (92.1) | 178 (91.3) |
Complications during the first 7Â days, n (%) | ||
 Respiratory failure | 23 (10.6) | 18 (9.2) |
 Renal failure | 7 (3.2) | 11 (5.6) |
 Hepatic failure | 2 (0.9) | 4 (2.1) |
Complications during the first 28Â days, n (%) | ||
 Transfusion-related acute lung injury | 0 (0.0) | 0 (0.0) |
 Cerebral infarction | 5 (2.3) | 2 (1.0) |
 Pulmonary embolism | 5 (2.3) | 2 (1.0) |
 Acute myocardial infarction | 0 (0.0) | 0 (0.0) |
 Bowel ischemia | 1 (0.5) | 1 (0.5) |
 Deep venous thrombosis | 24 (11.1) | 17 (8.7) |
 Sepsis | 5 (2.3) | 13 (6.7) |
Event-free days during the first 28Â days, median (IQR)a | ||
 ICU-free days | 19.0 (12.0–24.0) | 19.0 (8.0–24.0) |
 Ventilator-free days | 25.5 (18.0–28.0) | 24.0 (18.0–27.0) |
 Catecholamine-free days | 28.0 (27.0–28.0) | 28.0 (27.0–28.0) |